Antifungal Susceptibilities of Cryptococcus neoformans

Abstract

Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from Thailand, Malawi, and the United States and found no evidence of resistance or MIC profile differences among the countries.

Keywords

• Cryptococcus neoformans
• Malawi
• susceptibility testing
• Thailand
• United States